Torii Pharmaceutical Co Ltd - Strategic SWOT Analysis Review

Torii Pharmaceutical Co Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.

This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Report Scope

• Business description - A detailed description of the company’s operations and business divisions.
• Corporate strategy - The analyst’s summarization of the company’s business strategy.
• SWOT analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
• Company history - Progression of key events associated with the company.
• Major products and services - A list of major products, services and brands of the company.
• Key competitors - A list of key competitors to the company.
• Key employees - A list of the key executives of the company.
• Executive biographies - A brief summary of the executives’ employment history.
• Key operational heads - A list of personnel heading key departments/functions.
• Important locations and subsidiaries - A list of key locations and subsidiaries of the company, including contact details.

Highlights

Torii Pharmaceutical Co Ltd (Torii), a subsidiary of Shionogi & Co Ltd, is a pharmaceutical company. It develops and markets pharmaceutical products for chronic kidney disease (CKD), skin diseases, and allergies. The company’s product portfolio includes Enaroy tablets for renal anemia, Riona tablets as a phosphate binder for hyperphosphatemia and iron deficiency anemia, Remitch capsules for pruritus in dialysis patients and Remitch OD tablets for those with swallowing difficulties. Torii has introduced Corectim ointments, the first topical JAK inhibitors for atopic dermatitis, and Antebate in multiple forms for inflammation reduction. The company also markets Cedarcure and Miticure Sublingual tablets for Japanese cedar pollinosis and house dust mite allergies, respectively. Torii is headquartered in Chuo-ku, Tokyo, Japan.

Reasons to Buy

• Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
• Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
• Understand and respond to your competitors’ business structure and strategies with the analyst’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
• Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.

Note: Some sections may be missing if data is unavailable for the company.